Stock & Company Details
Celldex Therapeutics Inc. $CLDX
Price:
N/A
N/A
79M
$3.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
-8.97
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CLDX technical indicators
Latest Celldex Therapeutics Inc. (CLDX) indicator readings as of 2026-08-28.
CLDX's 14-day RSI is 45.5, in neutral territory. At $39.12 it is trading 25.4% above its 200-day moving average of $31.19, and above its 50-day average of $38.40. Price sits near the lower Bollinger Band ($37.95 to $44.60). ADX reads 21.6, sitting between trending and range-bound.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly effect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.
Finance Bot
Ask your questions
Start by typing a question below.
